Valuation Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.25 CNY | -0.60% |
|
-4.06% | -6.69% |
| 04-28 | Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-17 | Shenzhen YHLO Biotech receives notice of administrative penalty from regulator | RE |
Company Valuation: Shenzhen YHLO Biotech Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 13,993 | 11,142 | 12,993 | 9,010 | 8,114 | 7,571 | - |
| Change | - | -20.38% | 16.62% | -30.65% | -9.95% | -6.69% | - |
| Enterprise Value (EV) | 13,993 | 11,142 | 12,993 | 9,010 | 8,114 | 7,571 | 7,571 |
| Change | - | -20.38% | 16.62% | -30.65% | -9.95% | -6.69% | 0% |
| P/E ratio | 64x | 10.9x | 36.9x | 29.8x | 355x | 21.6x | 20.2x |
| PBR | 9.21x | - | 5.08x | 3.27x | 3.01x | 2.4x | 2.25x |
| PEG | - | 0x | -0.6x | -2.1x | -3.8x | 0x | 2.91x |
| Capitalization / Revenue | 11.8x | - | 6.33x | 4.52x | 4.48x | 3.11x | 2.96x |
| EV / Revenue | 0x | - | 0x | 0x | 0x | 3.11x | 2.96x |
| EV / EBITDA | - | - | 0x | 0x | 0x | 10.5x | 8.35x |
| EV / EBIT | 0x | - | 0x | 0x | 0x | 16.4x | 17.5x |
| EV / FCF | - | - | - | -0x | 0x | 28.5x | - |
| FCF Yield | - | - | - | -0.7% | 0.77% | 3.51% | - |
| Dividend per Share 2 | 0.2857 | - | - | 0.21 | 0.021 | 0.3 | - |
| Rate of return | 1.16% | - | - | 1.33% | 0.15% | 2.26% | - |
| EPS 2 | 0.3857 | 1.8 | 0.62 | 0.53 | 0.04 | 0.6125 | 0.655 |
| Distribution rate | 74.1% | - | - | 39.6% | 52.5% | 49% | - |
| Net sales 1 | 1,189 | - | 2,053 | 1,992 | 1,811 | 2,435 | 2,554 |
| EBITDA 1 | - | - | 529.8 | 941.4 | 407.8 | 720 | 907 |
| EBIT 1 | 235.7 | - | 340.5 | 307.5 | 111.5 | 460.3 | 432 |
| Net income 1 | 208.6 | - | 358.4 | 301.7 | 24.02 | 380.8 | 373.5 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 24.68 | 19.65 | 22.87 | 15.80 | 14.20 | 13.25 | 13.25 |
| Nbr of stocks (in thousands) | 567,000 | 567,000 | 568,129 | 570,267 | 571,388 | 571,388 | - |
| Announcement Date | 18/02/22 | 27/02/23 | 23/02/24 | 27/02/25 | 27/02/26 | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.63x | - | - | 2.26% | 1.11B | ||
| 63.62x | 7.57x | 41.32x | -.--% | 12.67B | ||
| 34.86x | - | - | -.--% | 9.34B | ||
| 29.73x | 5.88x | 16.41x | 1.33% | 5.6B | ||
| 18.18x | 1.71x | 9.05x | 2.66% | 5.57B | ||
| 32.05x | 9.66x | 24.47x | 0.52% | 4.81B | ||
| 19.48x | 3.41x | 16.21x | 3.39% | 4.4B | ||
| -11.22x | 2.63x | -11.52x | - | 2.07B | ||
| 36.13x | - | - | - | 1.69B | ||
| Average | 27.16x | 5.14x | 15.99x | 1.45% | 5.25B | |
| Weighted average by Cap. | 35.99x | 5.84x | 23.66x | 0.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 688575 Stock
- Valuation Shenzhen YHLO Biotech Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















